Clinical Trials Browser

Breast Neoplasms

NCT05455619 2026-04-22

Amelia-1

Phase 1/2 Recruiting

52 enrolled

Breast

Breast Neoplasms, Hyperglycemia, Hyperinsulinism, Insulin Resistance

NCT05683418 2026-04-22

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

Phase 1 Recruiting

241 enrolled

Breast

Breast Neoplasms, Hereditary Sensory and Autonomic Neuropathies

NCT06257264 2026-04-22

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Phase 1 Recruiting

258 enrolled

BreastGastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Clinical Trials

A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During Surgery

Amelia-1

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

Identifying Patterns in the Breath of Individuals With Breast Cancer

HER2 Vaccine for Locally Advanced Breast Cancer

PREDICT-RD

I-MAMMO

ALLIANCE

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

MAMO

Novel Body Composition Measurements in Association With Outcomes of Breast Reconstruction Reconstruction

Collection of Blood From Patients With Cancer

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

ELAINEIII

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

LINFO

CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer

MoonROSE

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

A Study of the TheraBionic P1 Device in Breast Cancer

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

FACT-TN

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Effectiveness of a Visual Biofeedback Program Versus Conventional Physiotherapy on Shoulder Mobility, Strength, and Function in Women After Breast Cancer Surgery

PERTUREAL

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

EUTACAM

Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

ELEGANCE

A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

reaINAVO

A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer

Effects of Physical Activity in Early Stage Hormone Receptor Positive Breast Cancer Patients

Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer

ADARNAT

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

Quantitative MRI Assessment of Breast Cancer Therapy Response

ANGEL

ECLECTIC

Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

CIPN

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

OMNIRAY